INTRODUCTION
============

Video-assisted thoracic surgery (VATS) in the supine position for lesions of the anterior mediastinum has become popular, and this procedure requires one-lung ventilation (OLV).[@B1][@B2][@B3] Surgical positions considerably influence the deterioration speed and nadir value of arterial oxygen tension (PaO~2~) after the start of OLV.[@B4][@B5] In contrast to the lateral decubitus position, preferential redistribution of pulmonary perfusion to the ventilated lung by gravity is absent during OLV in the supine position, resulting in the more frequent development of dangerous hypoxemia.[@B4][@B6]

Hypoxemia during OLV develops mainly due to the involvement of the intrapulmonary shunt (Qs/Qt) with blood flow through the capillaries of the non-ventilated lung and anesthesia-induced atelectasis in the ventilated lung, leading to a mismatch of the ratio of ventilation to perfusion (V/Q).[@B7][@B8][@B9] Alveolar recruitment (AR) is an effective ventilatory maneuver that reverts alveolar collapse by increasing the transpulmonary pressure. Positive end-expiratory pressure (PEEP) during OLV, by aiding AR and restoring functional residual capacity, has been proposed to minimize atelectasis in the ventilated lung and thus improve oxygenation.[@B10][@B11][@B12][@B13][@B14][@B15] On the other hand, the application of PEEP alone may paradoxically increase pulmonary vascular resistance and the shift of blood flow to the non-ventilated lung, leading to an increase in Qs/Qt and impairment of oxygenation.[@B15][@B16][@B17] Therefore, considering that only slight gravity-dependent pulmonary shift takes place in the supine position, PEEP per se likely demonstrates both positive and negative effects on Qs/Qt and V/Q matching. However, the effects of the AR maneuver and PEEP on oxygenation during OLV in the supine position have not been evaluated. We tested whether the AR maneuver with subsequent PEEP and PEEP alone could improve oxygenation during OLV in the supine position in patients undergoing VATS in a prospective and randomized trial. As secondary endpoints, the effects of the proposed treatment on Qs/Qt and physiologic dead space were also evaluated.

MATERIALS AND METHODS
=====================

This study was approved by the Institutional Review Board (ref: 4-2011-0301) and registered at <http://clinicaltrials.gov> (NCT 01652612). After written informed consent was obtained from all patients, 99 patients of ages 20-70 years with America Society of Anesthesiologists physical status class II or III who were scheduled for VATS in the supine position were enrolled in this study. Exclusion criteria included an expected duration of OLV \<30 min, uncompensated cardiac disease, chronic obstructive or restrictive pulmonary disease (preoperative forced expiratory volume in 1 second and forced vital capacity below 60% of the predicted value), and obesity (body mass index \>30 kg/m^2^). Patients were randomly allocated to one of three groups using a computerized randomization table one day before surgery by an independent anesthesiology nurse who was not involved in this study (control group: n=33; PEEP group: n=33; AR group: n=33).

Patients were monitored by electrocardiography and pulse oximetry, as well as by monitoring for nasopharyngeal temperature, invasive arterial pressure, and central venous pressure. Anesthesia was induced with propofol (1.5 mg/kg), remifentanil (0.5-1.0 µg/kg), and rocuronium (0.3-0.9 mg/kg) while monitoring for train-of-four stimulation. Anesthesia was maintained with sevoflurane (1.0-2.0 vol%) and remifentanil (0.1-0.3 µg/kg/min). The trachea was intubated using a left-sided double-lumen tube (Broncho-Cath®; Mallinckrodt Medical Inc., Athlone, Ireland); the correct position was confirmed using a fiberoptic bronchoscope after intubation and supine surgical positioning. A 7-Fr central venous catheter (Arrow International, Reading, PA, USA) was inserted via the right internal jugular vein. The insertion length of the central venous catheter was calculated using a height-based formula in order to place its tip near the right atrium,[@B18] which was confirmed by portable chest X-ray.

The lungs were initially ventilated using a constant-flow, volume-controlled ventilation mode (Zeus ventilator; Dräger Medical, Lübeck, Germany) with a tidal volume (VT) of 8 mL/kg predicted body weight, an inspiratory:expiratory (I:E) ratio of 1:2, an inspiratory pause of 10%, and a respiratory rate of 12 bpm in 100% oxygen without PEEP. After all patients were placed in the supine surgical position with pillows under each hemithorax allowing some degree of tilting (≤10°), the ventilator was switched to the pressure-controlled mode, adjusting the peak inspiratory pressure to obtain the same VT as during the volume-controlled mode. In the PEEP group, a PEEP of 8 cm H~2~O was applied. In the AR group, the AR maneuver was performed: the peak inspiratory pressure and PEEP were sequentially increased from 30/10 to 35/15 cm H~2~O in steps of five breaths and then to 40/20 cm H~2~O for ten breaths with an I:E ratio of 1:1. And then, the ventilator was set back to the baseline setting in the pressure-controlled mode at a PEEP of 8 cm H~2~O.[@B10][@B12] OLV was initiated at the moment of skin incision, and the tube lumen of the non-ventilated lung was opened to room air. During OLV, VT was reduced to 6 mL/kg, and the respiratory rate was adjusted to maintain an end-tidal CO~2~ tension (ETCO~2~) of 35-40 mm Hg.

During surgery, intrathoracic CO~2~ insufflation was accomplished at a set pressure of 8-10 mm Hg and was automatically controlled by a CO~2~ insufflator. During OLV, if SpO~2~ declined to \<90%, surgery was temporarily interrupted to resume intermittent two-lung ventilation (TLV) until SpO~2~ recovered to \>95%. After the OLV period, both lungs were re-expanded by hand bagging in all patients.

Arterial and central venous blood gas analyses, respiratory variables, and hemodynamic variables were recorded at the following points: 15 min into TLV (TLV~baseline~), 15 and 30 min after OLV (OLV~15~ and OLV~30~), and 10 min after the re-establishment of TLV (TLV~end~). Respiratory variables included the peak airway pressure (P~peak~), mean airway pressure (P~mean~), and dynamic lung compliance, which was calculated as VT/(P~peak~-PEEP). Physiologic (dead space to tidal volume ratio, VD/VT) was calculated according to the Hardman and Aitkenhead[@B19] equation: VD/VT=1.14×(PaCO~2~-E\'CO~2~)/PaCO~2~-0.005. The shunt fraction (Qs/Qt) was determined using the formula: Qs/Qt=(CcO~2~-CaO~2~)/(CcO~2~-CvO~2~), assuming that mixed venous O~2~ partial pressure was equal to central venous O~2~ partial pressure. Arterial and central venous blood samples were measured using an automated blood gas analyzer (Stat Profile ® CCX; Nova Biomedical, MA, USA). Hemodynamic measurements included the heart rate, mean arterial pressure, and central venous pressure.

Statistical analyses were performed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA). Data are presented as mean±standard deviation, or numbers as appropriate. Based on the results of a previous study evaluating the effect of the AR strategy in the lateral decubitus position,[@B11] we estimated that a sample of 31 patients per treatment group would be sufficient for detecting a 76-mm Hg mean difference of PaO~2~ between any two groups with a power of 0.8, a type I error of 0.05, and a standard deviation of 108 mm Hg. Factoring in a drop-out rate of 5%, we calculated that 33 patients would be required for each group. To assess for normality, the Kolmogorov-Smirnov (K-S) test was performed on the data set. Normally-distributed data were analyzed with a one-way analysis of variance for continuous variables. If there was a significant difference among the groups, a post hoc analysis using Bonferroni\'s test was performed. In cases where the K-S test demonstrated that data did not follow a normal distribution, comparisons between treatments were performed using the Kruskal-Wallis test, and Bonferroni correction was used for multiple comparisons. Categorical data were analyzed with a χ^2^ test. A *p* value less than 0.05 was considered to be statistically significant.

RESULTS
=======

One hundred six patients were assessed for eligibility; 99 of these patients consented to participate in the study and were randomly assigned to groups. Of the enrolled patients, seven patients were excluded from the study due to changes in the surgical plan during surgery; therefore, 92 patients completed the study ([Fig. 1](#F1){ref-type="fig"}). Patients\' characteristics and clinical data were similar among the groups ([Table 1](#T1){ref-type="table"}). None of the patients demonstrated dangerous hypoxemia (SpO~2~\<90%) for a 30-min OLV period regardless of the side of surgical approach.

The arterial and central venous blood gas data are shown in [Table 2](#T2){ref-type="table"}. PaO~2~ was higher at TLV~end~ (*p*=0.027) in the AR group than in the control group. The PaCO~2~-ETCO~2~ difference at OLV~15~ (*p*=0.043) and the estimated VD/VT at OLV~15~ and TLV~end~ (*p*\<0.05) decreased more in the AR group than in the control group ([Fig. 2](#F2){ref-type="fig"}). When compared with TLV~baseline~, PaO~2~ decreased while PaCO~2~ increased during OLV in all groups (*p*\<0.01). At TLV~end~, PaO~2~ did not return to baseline values only in the control group. Compared with TLV~baseline~, the estimated VD/VT increased at OLV~30~ and TLV~end~ (*p*\<0.05), and the PaCO~2~-ETCO~2~ difference increased during OLV and at TLV~end~ (*p*\<0.01) in the control group. Qs/Qt increased at OLV~30~ compared with TLV~baseline~ in all groups (*p*\<0.05).

Lung mechanics and hemodynamic data are presented in [Table 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}. During OLV and at TLV~end~, P~mean~ (*p*\<0.01) and dynamic lung compliance (*p*\<0.01) were higher in the PEEP and AR groups than in the control group. At TLV~end~, P~peak~ was higher in the PEEP and AR groups than in the control group (*p*\<0.01). Compared with TLV~baseline~, P~peak~, and P~mean~ increased during OLV and at TLV~end~ (*p*\<0.01) in all groups, whereas dynamic lung compliance decreased during OLV in all groups yet only in the control group at TLV~end~ (*p*\<0.01). No significant differences were found among the groups in terms of hemodynamic variables throughout the study period. Compared with TLV~baseline~, central venous pressure increased during OLV in all groups (*p*\<0.01), and the mean arterial pressure decreased at TLV~end~ in the control and AR groups (*p*\<0.05).

DISCUSSION
==========

This study investigated the effects of AR with subsequent PEEP and PEEP alone on oxygenation during OLV in the supine position. We observed that bilateral lung recruitment before the start of OLV not only improved the efficiency of ventilation but also increased arterial oxygenation with no significant change of Qs/Qt. Although dynamic lung compliance improved in both treatment groups, PEEP without recruitment did not lead to improved oxygenation.

The range of applications of VATS in treating mediastinal cysts and tumors has extended due to the evolution of surgical techniques; consequently, various patient positions require OLV.[@B1][@B2][@B20] Minimally invasive techniques offer the advantages of improved cosmesis, less surgical stress, shorter hospital durations, and efficacy equivalent to conventional open surgery.[@B3][@B21] However, hypoxemia related to one-lung anesthesia occurs with an incidence of approximately 5-10%, affecting postoperative outcomes such as cognitive dysfunction, renal failure, and pulmonary hypertension.[@B22][@B23] Compared with the lateral decubitus position, semilateral and supine surgical positions during OLV are associated with less gravity-induced redistribution of pulmonary perfusion to the ventilated lung, leading to higher Qs/Qt and more hypoxemia.[@B4][@B6] Additionally, anesthesia-induced atelectasis contributes to shunting in the ventilated lung regardless of the patient position.[@B8][@B9] In this study, two preventative ventilatory strategies in relation to atelectasis demonstrated increased dynamic lung compliance throughout the study period; however, only AR with subsequent PEEP resulted in improved efficiency of ventilation and oxygenation by reducing the physiologic dead space.

Dead space is the portion of ventilation that does not participate in gas exchange, indicating the degree of ventilatory efficiency.[@B24] OLV increases dead space and the PaCO~2~-ETCO~2~ difference, thereby requiring a greater minute ventilation to maintain the same level of PaCO~2~.[@B25] Our results are consistent with previous findings that AR improved the efficiency of alveolar ventilation during OLV, resulting in a lower PaCO~2~-ETCO~2~ difference and a reduced alveolar component of dead space, which is directly related to atelectasis and Qs/Qt.[@B10][@B11][@B12] In previous studies regarding AR, protocols were designed to apply a PEEP of 5-8 cm H~2~O in both treated and control patients undergoing thoracic surgery in the lateral position.[@B10][@B11] Although the application of PEEP has been known to be beneficial to the atelectatic areas, it did not improve efficiency of ventilation without a preemptive recruitment maneuver.[@B10][@B11][@B12][@B13][@B14][@B15] Additionally, PEEP applied to the ventilated lung may cause a shift of pulmonary blood flow to the non-ventilated lung and thus increase Qs/Qt, especially in the supine position, in which there is a similar influence of gravitational force on both lungs.[@B6][@B15][@B16][@B17] However, during OLV in the supine position in this study, Qs/Qt did not differ among the two treatments groups and the control group. Increased intrathoracic pressure caused by CO~2~ insufflation in the non-ventilated lung could be one possible explanation of similar Qs/Qt, as such pressure diverts pulmonary perfusion to the ventilated lung. Another explanation may be that the pressure-controlled mode during OLV might be associated with lower airway pressure and less compression of perialveolar vessels.[@B26]

Contrary to our expectations, OLV in the supine position was well tolerated, and SpO~2~ remained \>90% during a 30 minstudy period of OLV in all patients, whether they received treatment or not. Two previous studies evaluating oxygenation during OLV in the supine position have reported different incidences of hypoxemia.[@B4][@B6] In one previous trial, hypoxemia (SpO~2~\<90%) developed within 30 min of OLV in 82% of patients with normal preoperative pulmonary function undergoing micro-coagulation therapy for hepatic tumors.[@B4] In the other trial, although none of the patients developed hypoxemia, significantly lower PaO~2~ values were observed in the supine position than in the lateral position during a 15 min-study period of OLV before the start of surgery.[@B6] However, there were several differences between those studies and our study. First, the previous studies involved relatively small numbers of patients. Second, compared with a previous trial,[@B4] minimally invasive techniques performed in this study may contribute better oxygenation by decreasing both pain and surgical stress responses, which influence the development of hypoxemia.[@B27][@B28] Third, intrathoracic CO~2~ insufflation into the non-ventilated lung to facilitate exposure of the surgical field may contribute in shifting pulmonary perfusion to the ventilated lung.

The current study has several limitations. First, as this is the first study to compare the effects of the AR maneuver and PEEP during OLV in the supine position, we excluded patients with obesity or underlying pulmonary disease in order to avoid confounding factors. However, hypoxemia was observed in one patient of the control group using both side approaches in the second OLV episode. Therefore, the potential benefits of this ventilatory strategy could be more pronounced in patients with poor pulmonary function. Second, we included patients who underwent VATS using a bilateral approach, which may influence final PaO~2~ values after re-establishment of TLV. However, no difference was noted in the operative data among groups. Third, we calculated Qs/Qt based on right atrium blood samples instead of pulmonary arterial blood samples.

In summary, recruitment of both lungs with subsequent PEEP improved arterial oxygenation and ventilatory efficiency in patients undergoing VATS in the supine position. This strategy may reduce the risk of hypoxemia; however, it needs to be investigated further in high-risk patients.
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![Changes in the PaCO~2~-ETCO~2~ difference (A) and estimated VD/VT (B). PaCO~2~-ETCO~2~, arterial to end-tidal carbon dioxide tension difference; estimated VD/VT, physiologic dead space. ^\*^*p*\<0.05 vs. TLV~baseline~ in each group, ^†^*p*\<0.05 vs. control group.](ymj-56-1421-g002){#F2}

###### Demographic and Operative Data
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                                            Control group (n=31)   PEEP group (n=31)   AR group (n=30)
  ----------------------------------------- ---------------------- ------------------- -----------------
  Age (yr)                                  44±14                  49±14               46±14
  Male/female                               9/22                   6/25                13/17
  Body mass index (kg/m^2^)                 23.3±3.0               22.7±2.5            23.0±3.3
  Hypertension                              1                      4                   1
  Diabetes                                  3                      2                   0
  FVC (%)                                   97±13                  91±18               91±16
  FEV~1~ (%)                                106±14                 97±17               99±17
  FEV~1~/FVC (%)                            83±5                   80±8                84±7
  DLCO (%)                                  111±19                 105±16              107±21
  Hemoglobin (g/dL)                         12.2±1.1               12.0±0.9            12.3±1.1
  Duration of anesthesia (min)              126±43                 139±62              143±38
  Duration of surgery (min)                 82±42                  83±48               95±37
  Duration of one-lung ventilation (min)    67±39                  60±33               74±29
  Operation side (R/L)                      5/26                   4/27                8/22
  Operative diagnosis                                                                  
   Myasthenia gravis with/without thymoma   7/6                    6/8                 7/7
   Thymic cyst/tumors                       4/10                   11/6                2/11
   Bronchial cyst                           3                      0                   3
   Intrathoracic chest wall lipoma          1                      0                   0

FEV~1~, forced expiratory volume in 1 second; FVC, functional vital capacity; DLCO, diffusion capacity of lung for carbon monoxide; PEEP, positive end-expiratory pressure; AR, alveolar recruitment.

Values are number of patients or mean±SD.

###### Blood Gas Analysis Data
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  Group             TLV~baseline~   OLV~15~          OLV~30~          TLV~end~
  ----------------- --------------- ---------------- ---------------- ----------------
  PaO~2~ (mm Hg)                                                      
   Control          419.3±70.5      284.5±67.3^\*^   255.8±83.6^\*^   351.6±60.7^\*^
   PEEP             392.0±70.8      258.1±69.7^\*^   240.5±68.4^\*^   398.4±73.4
   AR               414.9±69.0      276.5±62.3^\*^   258.2±84.6^\*^   402.2±80.0^†^
  PcvO~2~ (mm Hg)                                                     
   Control          51.2±17.7       49.4±13.1        55.4±15.8        52.6±19.0
   PEEP             48.8±16.2       45.8±10.1        48.6±11.0        49.7±12.3
   AR               47.4±7.8        49.2±6.8         49.6±8.4         51.3±13.1
  PaCO~2~ (mm Hg)                                                     
   Control          31.1±4.4        40.0±4.6^\*^     39.2±5.7^\*^     34.6±4.9^\*^
   PEEP             30.7±3.4        39.2±5.3^\*^     39.6±6.0^\*^     37.1±7.0^\*^
   AR               32.8±5.0        41.0±7.5^\*^     41.4±6.2^\*^     36.0±5.7^\*^
  Qs/Qt (%)                                                           
   Control          16.7±7.7        23.3±8.6         29.0±12.2^\*^    22.9±11.4
   PEEP             18.0±4.5        21.9±6.6         25.1±7.5^\*^     18.1±7.7
   AR               16.3±4.6        21.1±8.2         25.9±10.2^\*^    17.1±6.4

PaO~2~, arterial oxygen tension; PcvO~2~, central venous oxygen tension; PaCO~2~, arterial carbon dioxide tension; Qs/Qt, intrapulmonary shunt fraction; TLV~baseline~, 15 min into TLV; OLV~15~ and OLV~30~, 15 min and 30 min after OLV; TLV~end~, 10 min after TLV was re-initiated; PEEP, positive end-expiratory pressure; AR, alveolar recruitment.

Values are mean±SD.

^\*^*p*\<0.05 vs. TLV~baseline~ in each group, ^†^*p*\<0.05 vs. control group.

###### Lung Mechanics
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  Group                TLV~baseline~   OLV~15~         OLV~30~         TLV~end~
  -------------------- --------------- --------------- --------------- ---------------
  Tidal volume (mL)                                                    
   Control             494±88          424±98^\*^      413±81^\*^      505±82
   PEEP                477±73          376±76^\*^      379±76^\*^      498±113
   AR                  513±104         404±104^\*^     403±109^\*^     491±97
  P~peak~ (cm H~2~O)                                                   
   Control             12.3±2.8        19.6±4.5^\*^    20.8±5.7^\*^    15.0±4.0^\*^
   PEEP                12.8±2.0        22.1±3.0^\*^    23.0±3.2^\*^    18.1±2.6^\*†^
   AR                  12.8±2.3        21.9±5.0^\*^    23.1±5.3^\*^    18.6±3.2^\*†^
  P~mean~ (cm H~2~O)                                                   
   Control             6.0±2.2         8.4±2.4^\*^     8.6±2.2^\*^     7.1±2.5^\*^
   PEEP                6.0±1.6         12.4±2.0^\*†^   12.1±2.0^\*†^   10.6±2.0^\*†^
   AR                  5.6±1.8         12.8±1.7^\*†^   13.1±1.8^\*†^   11.1±2.3^\*†^
  Cdyn (mL/cm H~2~O)                                                   
   Control             41.3±4.9        21.8±4.8^\*^    20.3±5.0^\*^    34.6±7.5^\*^
   PEEP                42.1±11.7       27.4±5.6^\*†^   26.8±6.5^\*†^   45.4±7.9^†^
   AR                  41.2±6.2        30.9±8.7^\*†^   29.1±8.2^\*†^   41.8±10.0^†^

P~peak~, peak airway pressure; P~mean~, mean airway pressure; Cdyn, dynamic lung compliance; TLV~baseline~, 15 min into TLV; OLV~15~ and OLV~30~, 15 min and 30 min after OLV; TLV~end~, 10 min after TLV was re-initiated; PEEP, positive end-expiratory pressure; AR, alveolar recruitment.

Values are mean±SD.

^\*^*p*\<0.05 vs. TLV~baseline~ in each group, ^†^*p*\<0.05 vs. control group.

###### Hemodynamic Changes
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  Group                    TLV~baseline~   OLV~15~    OLV~30~    TLV~end~
  ------------------------ --------------- ---------- ---------- -----------
  Heart rate (beats/min)                                         
   Control                 67±14           71±14      69±10      69±12
   PEEP                    67±15           70±13      68±12      69±11
   AR                      68±13           70±12      72±9       68±10
  MAP (mm Hg)                                                    
   Control                 83±13           90±12      86±11      79±11^\*^
   PEEP                    89±18           90±13      87±11      81±14
   AR                      89±13           91±15      88±11      79±10^\*^
  CVP (mm Hg)                                                    
   Control                 10±4            16±3^\*^   16±4^\*^   11±3
   PEEP                    10±3            17±4^\*^   16±4^\*^   11±4
   AR                      10±3            17±3^\*^   18±4^\*^   12±3

MAP, mean arterial pressure; CVP, central venous pressure; TLV~baseline~, 15 min into TLV; OLV~15~ and OLV~30~, 15 min and 30 min after OLV; TLV~end~, 10 min after TLV was re-initiated; PEEP, positive end-expiratory pressure; AR, alveolar recruitment.

Values are mean±SD.

^\*^*p*\<0.05 vs. TLV~baseline~ in each group.
